Suppliers / Shanghai Huilun Jiangsu Pharmaceutical

Shanghai Huilun Jiangsu Pharmaceutical

China Updated 9 July 2026

Shanghai Huilun Jiangsu Pharmaceutical is an API manufacturer based in China.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Cabozantinib SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Cabozantinib API

Questions about Shanghai Huilun Jiangsu Pharmaceutical

What does Shanghai Huilun Jiangsu Pharmaceutical make?
1 molecule is on record against Shanghai Huilun Jiangsu Pharmaceutical, including Cabozantinib. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shanghai Huilun Jiangsu Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Changzhou Pharmaceutical Factory shares 1 molecule Natco Pharma shares 1 molecule Biocon shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability